Mouse models of diabetic neuropathy

被引:155
作者
Sullivan, Kelli A. [1 ]
Hayes, John M. [1 ]
Wiggin, Timothy D. [1 ]
Backus, Carey [1 ]
Oh, Sang Su [1 ]
Lentz, Stephen I. [3 ]
Brosius, Frank, III [2 ]
Feldman, Eva L. [1 ]
机构
[1] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Div Nephrol, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Div Endocrinol & Metab, Dept Internal Med, Ann Arbor, MI 48109 USA
关键词
BKS; streptozotocin; B6Ins2(Akita); sciatic nerve; dorsal root ganglia; PERIPHERAL NEUROPATHY; NEUROTROPHIN TREATMENT; NITROSATIVE STRESS; ALDOSE REDUCTASE; COMPLICATIONS; APOPTOSIS; C57BL/6J; NEURONS; OBESITY; HYPERGLYCEMIA;
D O I
10.1016/j.nbd.2007.07.022
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Diabetic neuropathy (DN) is a debilitating complication of type 1 and type 2 diabetes. Rodent models of DN do not fully replicate the pathology observed in human patients. We examined DN in streptozotocin (STZ)-induced [B6] and spontaneous type 1 diabetes [B6Ins2(Akita)] and spontaneous type 2 diabetes [B6-db/db, BKS-db/db]. Despite persistent hyperglycemia, the STZ-treated B6 and B6Ins2(Akita) mice were resistant to the development of DN. In contrast, DN developed in both type 2 diabetes models: the B6-db/db and BKS-db/db mice. The persistence of hyperglycemia and development of DN in the B6-db/db mice required an increased fat diet while the BKS-db/ db mice developed severe DN and remained hyperglycemic on standard mouse chow. Our data support the hypothesis that genetic background and diet influence the development of DN and should be considered when developing new models of DN. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:276 / 285
页数:10
相关论文
共 57 条
[11]   Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice [J].
Christianson, JA ;
Ryals, JM ;
McCarson, KE ;
Wright, DE .
JOURNAL OF PAIN, 2003, 4 (09) :493-504
[12]   Restorative effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice [J].
Christianson, JA ;
Riekhof, JT ;
Wright, DE .
EXPERIMENTAL NEUROLOGY, 2003, 179 (02) :188-199
[13]   Ultrafine mapping of SNPs from mouse strains C57BL/6J, DBA/2J, and C57BLKS/J for loci contributing to diabetes and atherosclerosis susceptibility [J].
Davis, RC ;
Schadt, EE ;
Cervino, ACL ;
Péterfy, M ;
Lusis, AJ .
DIABETES, 2005, 54 (04) :1191-1199
[14]   Cis-acting expression quantitative trait loci in mice [J].
Doss, S ;
Schadt, EE ;
Drake, TA ;
Lusis, AJ .
GENOME RESEARCH, 2005, 15 (05) :681-691
[15]   The leptin-deficient (ob/ob) mouse -: A new animal model of peripheral neuropathy of type 2 diabetes and obesity [J].
Drel, Viktor R. ;
Mashtalir, Nazar ;
Ilnytska, Olga ;
Shin, Jeho ;
Li, Fei ;
Lyzogubov, Valeriy V. ;
Obrosova, Irina G. .
DIABETES, 2006, 55 (12) :3335-3343
[16]   Absence of diabetic hyperalgesia in bradykinin B1 receptor-knockout mice [J].
Gabra, BH ;
Merino, VF ;
Bader, M ;
Pesquero, JB ;
Sirois, P .
REGULATORY PEPTIDES, 2005, 127 (1-3) :245-248
[17]   Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus [J].
Gibran, NS ;
Jang, YC ;
Isik, FF ;
Greenhalgh, DG ;
Muffley, LA ;
Underwood, RA ;
Usui, ML ;
Larsen, J ;
Smith, DG ;
Bunnett, N ;
Ansel, JC ;
Olerud, JE .
JOURNAL OF SURGICAL RESEARCH, 2002, 108 (01) :122-128
[18]   Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse [J].
Goss, JR ;
Goins, WF ;
Lacomis, D ;
Mata, M ;
Glorioso, JC ;
Fink, DJ .
DIABETES, 2002, 51 (07) :2227-2232
[19]   Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy [J].
Ilnytska, Olga ;
Lyzogubov, Valeriy V. ;
Stevens, Martin J. ;
Drel, Viktor R. ;
Mashtalir, Nazar ;
Pacher, Pal ;
Yorek, Mark A. ;
Obrosova, Irina G. .
DIABETES, 2006, 55 (06) :1686-1694
[20]   Vascular calcification and osteolysis in diabetic neuropathy - is RANK-L the missing link? [J].
Jeffcoate, W .
DIABETOLOGIA, 2004, 47 (09) :1488-1492